Search results for "Decision Making"

showing 10 items of 492 documents

Biased Agonism in Drug Discovery—Is It Too Soon to Choose a Path?

2018

A single receptor can activate multiple signaling pathways that have distinct or even opposite effects on cell function. Biased agonists stabilize receptor conformations preferentially stimulating one of these pathways, and therefore allow a more targeted modulation of cell function and treatment of disease. Dedicated development of biased agonists has led to promising drug candidates in clinical development, such as the G protein-biased µ opioid receptor agonist oliceridine. However, leveraging the theoretical potential of biased agonism for drug discovery faces several challenges. Some of these challenges are technical, such as techniques for quantitative analysis of bias and development …

0301 basic medicineAgonistCell typemedicine.drug_classDecision MakingDrug AgonismOliceridineBiologyChoice BehaviorReceptors G-Protein-Coupled03 medical and health scienceschemistry.chemical_compoundDrug DiscoverymedicineFunctional selectivityAnimalsHumansReceptorPharmacologyDrug discoveryDrug Agonism030104 developmental biologychemistryMolecular MedicineSignal transductionNeuroscienceMolecular Pharmacology
researchProduct

Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit

2020

Ursodeoxycholic acid (UDCA) is a hydrophilic bile acid with an established benefit for patients suffering from primary biliary cholangitis (PBC). It was first introduced in the 60s and took until the late 90s to demonstrate a survival benefit in large meta-cohort studies.1 Since then, UDCA is the established first-line therapy according to current guidelines.2 The benefit of UDCA is multidimensional, and patients receiving UDCA experience increased transplant-free survival, a decreased risk of hepatocellular carcinoma and potentially improved quality of life.3–5 The survival benefit is predicted by a number biochemical markers that reflect cholestasis and that are accepted surrogates of the…

0301 basic medicineCholagogues and Cholereticsmedicine.medical_specialty2312Cholangitismedicine.drug_classBiliary cirrhosisclinical decision makingliverGastroenterologyhepatobiliary disease03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePrimary biliary cirrhosisCholestasisInternal medicinemedicineHumans1506BezafibrateHepatologyBile acidLiver Cirrhosis Biliarybusiness.industryUrsodeoxycholic AcidGastroenterologyObeticholic acidmedicine.diseaseUrsodeoxycholic acidLiver Transplantationprimary biliary cirrhosis030104 developmental biologychemistryHepatocellular carcinoma030211 gastroenterology & hepatologybusinessmedicine.drugGut
researchProduct

Designing food packaging for the Spanish market: Do motivations differ between involved and non-involved adolescents?

2018

Abstract This paper investigates the relationships among food choice motivations and the relevance of packaging elements (visual and informative elements) in the adolescent market. In addition, these relationships are re-tested in two different frameworks: high-involved consumers and low-involved consumers. 590 young consumers between 13 and 17 years were interviewed at the door of their public or private schools. Structural Modelling was used to test our hypotheses. The first analysis was done considering the global sample. The second one split off the sample into two groups: 351 high-involved adolescents and 239 low-involved adolescents. Our results showed, on one side, that weight contro…

0301 basic medicineHealth Knowledge Attitudes PracticeAdolescentAttitude of Health PersonnelDecision MakingSample (statistics)Product LabelingAffect (psychology)Choice BehaviorFood Preferences03 medical and health sciencesSurveys and Questionnaires0502 economics and businessFood choicemedicineHumansRelevance (information retrieval)MarketingMarketingMotivationSchools030109 nutrition & dietetics05 social sciencesCommerceFood PackagingHispanic or LatinoWeight controlConsumer BehaviorTest (assessment)Food packaging050211 marketingCuesmedicine.symptomPsychologyFood ScienceDietingFood Research International
researchProduct

A screen for constituents of motor control and decision making in Drosophila reveals visual distance-estimation neurons

2016

AbstractClimbing over chasms larger than step size is vital to fruit flies, since foraging and mating are achieved while walking. Flies avoid futile climbing attempts by processing parallax-motion vision to estimate gap width. To identify neuronal substrates of climbing control, we screened a large collection of fly lines with temporarily inactivated neuronal populations in a novel high-throughput assay described here. The observed climbing phenotypes were classified; lines in each group are reported. Selected lines were further analysed by high-resolution video cinematography. One striking class of flies attempts to climb chasms of unsurmountable width; expression analysis guided us to C2 …

0301 basic medicineMaleFormative FeedbackDecision MakingWalkingBiologyMotor ActivityArticle03 medical and health sciencesInterneuronsddc:570Expression analysisAnimalsDrosophilaMultidisciplinarybusiness.industryDistance PerceptionOptic Lobe NonmammalianMotor controlDepolarizationbiology.organism_classificationVisual distance030104 developmental biologyDrosophila melanogasterClimbingGap widthFemaleArtificial intelligencebusinessNeurosciencehuman activities
researchProduct

Three-dimensional analysis of the physiological foramen geometry of maxillary and mandibular molars by means of micro-CT.

2017

The aim of this study was to investigate the physiological foramen diameter, shape and distance between physiological and anatomical apex of maxillary and mandibular first and second molars. Accurate knowledge of the physiological foramina morphology; thus, inherent mechanical shaping technical hindrances, is decisive when taking the corresponding root canal final preparation decision. The morphological dimensions of a total of 1727 physiological foramina were investigated by means of micro-computed tomography. Mean narrow and wide (to a high number, oval) diameters of the physiological foramen were 0.24, 0.22 and 0.33 mm and 0.33, 0.31 and 0.42 mm in mesiobuccal (MB), distobuccal (DB) and …

0301 basic medicineMolarThree dimensional analysisRoot canalDecision MakingDentistry610 Medicine & healthIn Vitro TechniquesMandibular first molarMandibular second molar03 medical and health sciencesmaxillary and mandibular molars morphology0302 clinical medicineTooth Apexstomatognathic system10066 Clinic of Conservative and Preventive DentistryForamenmedicineHumansapical constrictionphysiological foramenmicro-computed tomography610 Medicine & healthGeneral DentistryMathematicsbusiness.industryDistobuccalX-Ray Microtomography030206 dentistryMolar3500 General DentistryApex (geometry)030104 developmental biologymedicine.anatomical_structureOriginal ArticleDental Pulp Cavitybusinessfinal apical fileRoot Canal Preparation
researchProduct

Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients

2016

In the last 20 years, following the identification of the BRCA1 and BRCA2 genes (hereinafter referred to as the BRCA genes), preventive pathways have been developed for the identification and clinical management of individuals at high risk of developing breast and ovarian cancer due to the presence of a pathogenic variant in either of these genes. These pathways are aimed at educating high-risk subjects on programs targeted toward early diagnosis and cancer risk reduction. The approval of a novel class of drugs, the PARP enzyme inhibitors, for the treatment of ovarian cancer patients carrying high-risk BRCA pathogenic variants has changed this scenario. BRCA testing, in addition to providin…

0301 basic medicineOncologyCancer ResearchGenes BRCA2Genes BRCA1Brca testingBRCA1; BRCA2; genetic testing; germline mutations; ovarian cancer; PARP inhibitors; somatic mutations; Oncology; Cancer ResearchSettore MED/03 - GENETICA MEDICA0302 clinical medicineClinical decision makingInformed consentsomatic mutationBRCA1 BRCA2 genetic testing germline mutations somatic mutations ovarian cancer PARP inibitorsDisease management (health)PARP inhibitorsOvarian NeoplasmsTumorInformed Consentmedicine.diagnostic_testDisease ManagementGeneral MedicinePrognosisBRCA1; BRCA2; genetic testing; germline mutations; ovarian cancer; PARP inhibitors; somatic mutations; Biomarkers Tumor; Clinical Decision-Making; Disease Management; Female; Genes BRCA1; Genetic Variation; Germ-Line Mutation; Humans; Informed Consent; Mutation; Ovarian Neoplasms; Prognosis; Genes BRCA2; Genetic Testing; Oncology; Cancer Researchovarian cancergermline mutationOncology030220 oncology & carcinogenesisgermline mutationsFemaleHumanmedicine.medical_specialtyPrognosiClinical Decision-MakingMEDLINEgenetic testing03 medical and health sciencesPARP inibitorsInternal medicinemedicineBiomarkers TumorHumansGerm-Line MutationGenetic testingGynecologyBRCA1; BRCA2; PARP inhibitors; genetic testing; germline mutations; ovarian cancer; somatic mutationsbusiness.industryOvarian NeoplasmGenetic Variationmedicine.diseaseBRCA1BRCA2030104 developmental biologyPARP inhibitorGenesMutationsomatic mutationsOvarian cancerbusinessBiomarkers
researchProduct

Gender medicine and oncology: report and consensus of an ESMO workshop.

2019

Background: The importance of sex and gender as modulators of disease biology and treatment outcomes is well known in other disciplines of medicine, such as cardiology, but remains an undervalued issue in oncology. Considering the increasing evidence for their relevance, European Society for Medical Oncology decided to address this topic and organized a multidisciplinary workshop in Lausanne, Switzerland, on 30 November and 1 December 2018.

0301 basic medicineOncologyMalemedicine.medical_specialtypopulation pharmacokinetic analysissuperior survivalDecision MakingMEDLINElymphomaDiseaseclearanceMedical Oncology03 medical and health sciences0302 clinical medicinerituximabInternal medicineNeoplasmsPhysiciansEpidemiologymedicinegendermelanomasexcancerHumansDosingfemale-patientsSex Characteristicsbusiness.industrygender medicineCancerHematologymedicine.diseaseChemotherapy regimenClinical trial030104 developmental biologyTreatment Outcome030220 oncology & carcinogenesisoncologyimpactBody CompositionFemalepharmacologybusinesssex-differencesSex characteristicsAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Quantum field inspired model of decision making: Asymptotic stabilization of belief state via interaction with surrounding mental environment

2018

This paper is devoted to justification of quantum-like models of the process of decision making based on the theory of open quantum systems, i.e. decision making is considered as decoherence. This process is modeled as interaction of a decision maker, Alice, with a mental (information) environment ${\cal R}$ surrounding her. Such an interaction generates "dissipation of uncertainty" from Alice's belief-state $\rho(t)$ into ${\cal R}$ and asymptotic stabilization of $\rho(t)$ to a steady belief-state. The latter is treated as the decision state. Mathematically the problem under study is about finding constraints on ${\cal R}$ guaranteeing such stabilization. We found a partial solution of th…

0301 basic medicinePersuasionClass (set theory)Psychology (all)Quantum decoherenceDissipation of uncertaintyProcess (engineering)Computer sciencemedia_common.quotation_subjectBF050105 experimental psychology03 medical and health sciences0501 psychology and cognitive sciencesQuantum field theoryQAQuantumGeneral Psychologymedia_commonQuantum-like modelVoters’ behaviorApplied Mathematics05 social sciencesState (functional analysis)16. Peace & justiceMental environmentMental (information) environment030104 developmental biologyQuantitative Biology - Neurons and CognitionOpen quantum systemFOS: Biological sciencesConsumers’ persuasionNeurons and Cognition (q-bio.NC)Decision makingMathematical economics
researchProduct

Octopamine Shifts the Behavioral Response From Indecision to Approach or Aversion in Drosophila melanogaster

2018

Animals must make constant decisions whether to respond to external sensory stimuli or not to respond. The activation of positive and/or negative reinforcers might bias the behavioral response towards approach or aversion. To analyze whether the activation of the octopaminergic neurotransmitter system can shift the decision between two identical odor sources, we active in Drosophila melanogaster different sets of octopaminergic neurons using optogenetics and analyze the choice of the flies using a binary odor trap assay. We show that the release of octopamine from a set of neurons and not acetylcholine acts as positive reinforcer for one food odor source resulting in attraction. The activat…

0301 basic medicineTβhCognitive NeuroscienceSensory systemOptogeneticsPositive Reinforcerdecision makinglcsh:RC321-57103 medical and health sciencesBehavioral Neurosciencechemistry.chemical_compound0302 clinical medicineethanol attractionoctopaminefood odoraversionNeurotransmitterlcsh:Neurosciences. Biological psychiatry. NeuropsychiatryOriginal ResearchbiologyOctopamine (drug)biology.organism_classificationAttraction030104 developmental biologyNeuropsychology and Physiological PsychologychemistryOdorDrosophila melanogasterNeuroscience030217 neurology & neurosurgeryNeuroscienceattractionFrontiers in Behavioral Neuroscience
researchProduct

Antiviral therapy in the palliative setting of HCC (BCLC-B and -C)

2020

The potential impact of direct-acting antivirals (DAAs) in patients with Barcelona Clinic Liver Cancer (BCLC)-B/C stage hepatocellular carcinoma (HCC) is understudied. Patients with HCC have been systematically excluded from randomised controlled trials evaluating the effectiveness of DAAs. Thus, the benefits of DAAs in patients with HCC are less well defined. The presence of active HCC before the initiation of DAA treatment is reported to be a predictor of DAA failure, and studies in patients without HCC have demonstrated that improvements in cirrhosis complications were lower or absent after DAA failure. Even if viral eradication is achieved using DAAs, reversal of liver function impairme…

0301 basic medicinemedicine.medical_specialtyCirrhosisrecurrenceCarcinoma Hepatocellularmedicine.medical_treatmentDecision MakingLiver transplantationAntiviral AgentsRisk Assessment03 medical and health sciences0302 clinical medicineMedicineHumansStage (cooking)HCCIntensive care medicineDAANeoplasm StagingAntiviral Agent...Hepatologybusiness.industryLiver NeoplasmsPalliative CareCancerHepatitis C Chronicmedicine.diseaseBCLC Stage030104 developmental biologyBCLC-Dliver functionHepatocellular carcinoma030211 gastroenterology & hepatologyLiver functionbusinessLiver cancerBCLC-BBCLC-CHuman
researchProduct